Drug Profile
Nitisinone - Cycle Pharmaceuticals
Alternative Names: NITYRLatest Information Update: 17 Mar 2021
Price :
$50
*
At a glance
- Originator Cycle Pharmaceuticals
- Class Antiparkinsonians; Cyclohexanones; Nitrobenzoates; Small molecules
- Mechanism of Action 4-hydroxyphenylpyruvate dioxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Tyrosinaemia type I